ONCY Latest Headlines

Oncolytics Biotech Highlights Pelareorep’s Tumor-Activating Potential

at www.tipranks.com (Tue, 29-Sep 10:00 AM)

Oncolytics Advances Pelareorep Trial, Gains FDA Alignment

at www.tipranks.com (Mon, 28-Sep 9:58 AM)

Analysts Offer Insights on Healthcare Companies: Oncolytics Biotech (ONCY) and Spyre Therapeutics (SYRE)

at www.tipranks.com (Sun, 27-Sep 5:30 PM)

Oncolytics Biotech Advances toward Potential FDA Registration with Expanded Colorectal Cancer Trial

Market Chameleon (Mon, 13-Jul 10:30 AM)